title: Bidil: recontextualizing the race debate.
authors.affiliation: Program on Life Sciences, Ethics and Policy, McLaughlin-Rotman Centre for Global Health, University Health Network/McLaughlin Centre for Molecular Medicine at University of Toronto, MaRS Centre, South Tower, Toronto, Ontario, Canada.
authors.forename: B
authors.initials: B
authors.lastname: Séguin
authors.forename: B
authors.initials: B
authors.lastname: Hardy
authors.forename: P A
authors.initials: PA
authors.lastname: Singer
authors.forename: A S
authors.initials: AS
authors.lastname: Daar
mesh_terms: D001741:Black or African American / Q000235:genetics*; D002986:Clinical Trials as Topic; D017277:Drug Approval; D004338:Drug Combinations; D006333:Heart Failure / Q000188:drug therapy* / Q000208:ethnology*; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use*; D007548:Isosorbide Dinitrate / Q000627:therapeutic use*; D010597:Pharmacogenetics; D044469:Racial Groups / Q000145:classification*; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D004338:Drug Combinations; C431665:isosorbide-hydralazine combination; D006830:Hydralazine; D007548:Isosorbide Dinitrate